vs

Side-by-side financial comparison of MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) and TELOS CORP (TLS). Click either name above to swap in a different company.

MARAVAI LIFESCIENCES HOLDINGS, INC. is the larger business by last-quarter revenue ($49.9M vs $46.8M, roughly 1.1× TELOS CORP). TELOS CORP runs the higher net margin — -34.9% vs -71.6%, a 36.7% gap on every dollar of revenue. On growth, TELOS CORP posted the faster year-over-year revenue change (77.4% vs -11.8%). TELOS CORP produced more free cash flow last quarter ($8.0M vs $-24.9M). Over the past eight quarters, TELOS CORP's revenue compounded faster (25.7% CAGR vs -11.9%).

Maravai LifeSciences Holdings is a global life sciences firm developing critical reagents, diagnostic products, and tech solutions to support biopharma research, drug development, clinical diagnostics, and cell/gene therapy manufacturing. It serves biotech, pharma, research bodies and labs worldwide across three core segments.

Telos Corporation is an information technology and cybersecurity company located in Ashburn, Virginia. Telos primarily serves government and enterprise clients, receiving a large number of its contracts from the United States Department of Defense. Customers are primarily military, intelligence and civilian agencies of the US government and NATO allies.

MRVI vs TLS — Head-to-Head

Bigger by revenue
MRVI
MRVI
1.1× larger
MRVI
$49.9M
$46.8M
TLS
Growing faster (revenue YoY)
TLS
TLS
+89.2% gap
TLS
77.4%
-11.8%
MRVI
Higher net margin
TLS
TLS
36.7% more per $
TLS
-34.9%
-71.6%
MRVI
More free cash flow
TLS
TLS
$32.8M more FCF
TLS
$8.0M
$-24.9M
MRVI
Faster 2-yr revenue CAGR
TLS
TLS
Annualised
TLS
25.7%
-11.9%
MRVI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MRVI
MRVI
TLS
TLS
Revenue
$49.9M
$46.8M
Net Profit
$-35.7M
$-16.3M
Gross Margin
25.8%
35.0%
Operating Margin
-117.9%
-39.6%
Net Margin
-71.6%
-34.9%
Revenue YoY
-11.8%
77.4%
Net Profit YoY
-37.7%
-74.8%
EPS (diluted)
$-0.24
$-0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MRVI
MRVI
TLS
TLS
Q4 25
$49.9M
$46.8M
Q3 25
$41.6M
$51.4M
Q2 25
$47.4M
$36.0M
Q1 25
$46.9M
$30.6M
Q4 24
$56.6M
$26.4M
Q3 24
$69.0M
$23.8M
Q2 24
$69.4M
$28.5M
Q1 24
$64.2M
$29.6M
Net Profit
MRVI
MRVI
TLS
TLS
Q4 25
$-35.7M
$-16.3M
Q3 25
$-25.6M
$-2.1M
Q2 25
$-39.6M
$-9.5M
Q1 25
$-29.9M
$-8.6M
Q4 24
$-25.9M
$-9.3M
Q3 24
$-97.1M
$-28.1M
Q2 24
$-9.8M
$-7.8M
Q1 24
$-12.1M
$-7.4M
Gross Margin
MRVI
MRVI
TLS
TLS
Q4 25
25.8%
35.0%
Q3 25
13.6%
39.9%
Q2 25
16.4%
33.2%
Q1 25
16.5%
39.8%
Q4 24
34.3%
40.3%
Q3 24
46.7%
13.2%
Q2 24
44.4%
34.1%
Q1 24
40.3%
37.0%
Operating Margin
MRVI
MRVI
TLS
TLS
Q4 25
-117.9%
-39.6%
Q3 25
-98.6%
-4.8%
Q2 25
-139.8%
-27.5%
Q1 25
-104.9%
-29.5%
Q4 24
-66.7%
-37.6%
Q3 24
-239.9%
-121.4%
Q2 24
-19.4%
-30.3%
Q1 24
-29.4%
-28.5%
Net Margin
MRVI
MRVI
TLS
TLS
Q4 25
-71.6%
-34.9%
Q3 25
-61.4%
-4.1%
Q2 25
-83.5%
-26.5%
Q1 25
-63.9%
-28.1%
Q4 24
-45.8%
-35.4%
Q3 24
-140.6%
-118.0%
Q2 24
-14.1%
-27.2%
Q1 24
-18.8%
-24.9%
EPS (diluted)
MRVI
MRVI
TLS
TLS
Q4 25
$-0.24
$-0.22
Q3 25
$-0.18
$-0.03
Q2 25
$-0.27
$-0.13
Q1 25
$-0.21
$-0.12
Q4 24
$-0.21
$-0.13
Q3 24
$-0.68
$-0.39
Q2 24
$-0.07
$-0.11
Q1 24
$-0.09
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MRVI
MRVI
TLS
TLS
Cash + ST InvestmentsLiquidity on hand
$216.9M
$53.2M
Total DebtLower is stronger
$291.8M
Stockholders' EquityBook value
$212.4M
$96.0M
Total Assets
$770.6M
$139.9M
Debt / EquityLower = less leverage
1.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MRVI
MRVI
TLS
TLS
Q4 25
$216.9M
$53.2M
Q3 25
$243.6M
$59.0M
Q2 25
$269.9M
$57.0M
Q1 25
$285.1M
$57.8M
Q4 24
$322.4M
$54.6M
Q3 24
$578.2M
$69.8M
Q2 24
$573.2M
$80.1M
Q1 24
$561.7M
$93.9M
Total Debt
MRVI
MRVI
TLS
TLS
Q4 25
$291.8M
Q3 25
$292.8M
Q2 25
$293.9M
Q1 25
$294.9M
Q4 24
$295.9M
Q3 24
$521.7M
Q2 24
$522.5M
Q1 24
$523.3M
Stockholders' Equity
MRVI
MRVI
TLS
TLS
Q4 25
$212.4M
$96.0M
Q3 25
$245.4M
$119.7M
Q2 25
$265.9M
$118.4M
Q1 25
$300.6M
$126.1M
Q4 24
$325.3M
$127.1M
Q3 24
$344.9M
$129.5M
Q2 24
$434.7M
$149.1M
Q1 24
$410.7M
$154.4M
Total Assets
MRVI
MRVI
TLS
TLS
Q4 25
$770.6M
$139.9M
Q3 25
$849.2M
$164.3M
Q2 25
$897.0M
$165.0M
Q1 25
$959.8M
$158.1M
Q4 24
$1.0B
$158.2M
Q3 24
$1.3B
$166.3M
Q2 24
$1.4B
$182.4M
Q1 24
$1.4B
$195.4M
Debt / Equity
MRVI
MRVI
TLS
TLS
Q4 25
1.37×
Q3 25
1.19×
Q2 25
1.11×
Q1 25
0.98×
Q4 24
0.91×
Q3 24
1.51×
Q2 24
1.20×
Q1 24
1.27×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MRVI
MRVI
TLS
TLS
Operating Cash FlowLast quarter
$-22.8M
$8.0M
Free Cash FlowOCF − Capex
$-24.9M
$8.0M
FCF MarginFCF / Revenue
-49.9%
17.0%
Capex IntensityCapex / Revenue
4.2%
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-70.7M
$29.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MRVI
MRVI
TLS
TLS
Q4 25
$-22.8M
$8.0M
Q3 25
$-15.2M
$9.1M
Q2 25
$-10.3M
$7.0M
Q1 25
$-9.4M
$6.1M
Q4 24
$-14.6M
$-10.5M
Q3 24
$13.1M
$-7.1M
Q2 24
$17.4M
$-8.0M
Q1 24
$-8.5M
$-350.0K
Free Cash Flow
MRVI
MRVI
TLS
TLS
Q4 25
$-24.9M
$8.0M
Q3 25
$-18.1M
$8.7M
Q2 25
$-13.1M
$6.8M
Q1 25
$-14.6M
$6.0M
Q4 24
$-20.5M
$-12.4M
Q3 24
$4.5M
$-7.1M
Q2 24
$7.9M
$-8.2M
Q1 24
$-14.1M
$-447.0K
FCF Margin
MRVI
MRVI
TLS
TLS
Q4 25
-49.9%
17.0%
Q3 25
-43.4%
16.9%
Q2 25
-27.7%
19.0%
Q1 25
-31.2%
19.5%
Q4 24
-36.2%
-47.0%
Q3 24
6.6%
-30.0%
Q2 24
11.4%
-28.9%
Q1 24
-22.0%
-1.5%
Capex Intensity
MRVI
MRVI
TLS
TLS
Q4 25
4.2%
0.1%
Q3 25
7.0%
0.9%
Q2 25
6.1%
0.4%
Q1 25
11.2%
0.4%
Q4 24
10.3%
7.1%
Q3 24
12.4%
0.2%
Q2 24
13.8%
0.8%
Q1 24
8.8%
0.3%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MRVI
MRVI

Cygnus Segment$27.2M54%
Other$18.4M37%
Shipping And Handling$4.3M9%

TLS
TLS

Security Solutions Segment$44.8M96%
Secure Networks Segment$1.9M4%

Related Comparisons